Breaking News Instant updates and real-time market news.

SENS

Senseonics

$0.97

-0.0409 (-4.05%)

16:07
09/30/19
09/30
16:07
09/30/19
16:07

Senseonics completes U.S. patient enrollment in PROMISE 180-day clinical study

Senseonics Holdings announced the completion of patient enrollment in the Eversense PROMISE 180-day sensor Clinical Study. The PROMISE Clinical Study is intended to evaluate the safety and efficacy of the Eversense CGM System in people with diabetes over a 180-day period for the pre-market application submission to the U.S. Food and Drug Administration. This system has previously received its CE Mark and is currently commercially available across Europe. The 181 study participants at 8 sites across the United States had the Eversense CGM System inserted subcutaneously as part of the study. "I am thrilled to be able to offer a long-term implantable sensor to my patients through the Eversense 180-day clinical study," said Satish Garg, MD, Professor of Medicine and Pediatrics at the Barbara Davis Center, University of Colorado Health. "This long-term CGM could be a game changer for people with diabetes. At the Barbara Davis Center, we actively participate in clinical trials that bring the latest diabetes technology and treatments to patients which change the way they manage their diabetes - now and in the future. The PROMISE study promises to do so."

SENS Senseonics
$0.97

-0.0409 (-4.05%)

06/06/19
PIPR
06/06/19
NO CHANGE
PIPR
Senseonics receives FDA claim for Eversense CGM system, says Piper Jaffray
Piper Jaffray analyst JP McKim maintained a Neutral rating and $2.70 price target on Senseonics, while noting that the company "received a non-adjunctive claim for their Eversense CGM system" from the FDA. The analyst said that the claim would allow Eversense "to be used in replacement for finger stick glucose measurements" and added that it "is a needed claim to begin the process to unlock the Medicare population and represents an important stage in their commercialization process."
07/05/19
RAJA
07/05/19
DOWNGRADE
RAJA
Market Perform
Senseonics downgraded to Market Perform from Outperform at Raymond James
Raymond James analyst Jayson Bedford downgraded Senseonics to Market Perform from Outperform. The analyst says the company's "persistent headwinds" leave him "less patient" with respect to the shares.
07/05/19
07/05/19
NO CHANGE

Fly Intel: Top five analyst actions
Catch up on today's top five analyst actions with this list compiled by The Fly: 1. Teva (TEVA) upgraded to Buy from Hold at Argus with analyst Jason McCarthy saying the company has been making progress in resolving its "numerous challenges" of the past several years. 2. Senseonics (SENS) downgraded to Market Perform from Outperform at Raymond James with analyst Jayson Bedford stating the company's "persistent headwinds" leave him "less patient" with respect to the shares. 3.Omnova Solutions (OMN) downgraded to Hold from Buy at Deutsche Bank with analyst David Begleiter saying he believes Synthomer paid a "fair but full price" to acquire Omnova and that a competing bidder is unlikely to emerge. 4. Mercer (MERC) downgraded to Neutral from Outperformer at CIBC. 5. BASF (BASFY) initiated with a Neutral at Goldman Sachs. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/04/19
PIPR
09/04/19
NO CHANGE
Target $2.2
PIPR
Neutral
Massachusetts and Idaho two 'nice wins' for Senseonics, says Piper Jaffray
Blue Cross Blue Shield of Massachusetts and Idaho issued positive coverage decisions for Senseonics' Eversense, adding ~3.5M lives, Piper Jaffray analyst JP McKim tells investors in a research note. The stock should react positively to the coverage decision, which are "nice wins," adds the analyst, who notes that Boston has large diabetes centers. McKim, however, keeps a Neutral rating on Senseonics with a $2.20 price target.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
11/14/19
11/14
11:17
11/14/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
11/14/19
11/14
11:16
11/14/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
11/14/19
11/14
11:15
11/14/19
11:15
General news
Powell on changing policy: »

Powell on changing…

11:15
11/14/19
11/14
11:15
11/14/19
11:15
General news
Breaking General news story  »

4-Week Bill Auction to be…

11:15
11/14/19
11/14
11:15
11/14/19
11:15
General news
Breaking General news story  »

8-Week Bill Auction to be…

BA

Boeing

$362.00

-0.42 (-0.12%)

11:14
11/14/19
11/14
11:14
11/14/19
11:14
Hot Stocks
Breaking Hot Stocks news story on Boeing »

Boeing moves to session…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

11:11
11/14/19
11/14
11:11
11/14/19
11:11
General news
3-Month Bill Announcement Offering Amount data reported »

3-Month Bill Announcement…

11:11
11/14/19
11/14
11:11
11/14/19
11:11
General news
10-Yr TIPS Announcement CUSIP Number data reported »

10-Yr TIPS Announcement…

11:11
11/14/19
11/14
11:11
11/14/19
11:11
General news
10-Yr TIPS Announcement Offering Amount data reported »

10-Yr TIPS Announcement…

11:10
11/14/19
11/14
11:10
11/14/19
11:10
General news
6-Month Bill Announcement Offering Amount data reported »

6-Month Bill Announcement…

BMRN

BioMarin

$75.55

-0.54 (-0.71%)

11:07
11/14/19
11/14
11:07
11/14/19
11:07
Hot Stocks
BioMarin sees GAAP break-even or better in 2020 assuming Valoctocogene launch »

BioMarin Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

GILD

Gilead

$62.48

-0.85 (-1.34%)

11:05
11/14/19
11/14
11:05
11/14/19
11:05
Options
Gilead call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

11:05
11/14/19
11/14
11:05
11/14/19
11:05
General news
Powell:the day of reckoning could be "quite far off," »

Powell:the day of…

USO

United States Oil Fund

$12.05

0.09 (0.75%)

11:00
11/14/19
11/14
11:00
11/14/19
11:00
General news
Crude inventories for week of November 8 »

Crude oil inventories…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$263.91

-0.61 (-0.23%)

10:58
11/14/19
11/14
10:58
11/14/19
10:58
On The Fly
Maxim says sell Apple on concern about 2020 iPhone sales »

Maxim analyst Nehal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APD

Air Products

$237.81

0.17 (0.07%)

10:56
11/14/19
11/14
10:56
11/14/19
10:56
Periodicals
Breaking Periodicals news story on Air Products »

Lombard Odier's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:55
11/14/19
11/14
10:55
11/14/19
10:55
General news
Powell: the U.S. is the star economy »

Powell: the U.S. is the…

OPTT

Ocean Power

$1.49

-0.005 (-0.33%)

10:55
11/14/19
11/14
10:55
11/14/19
10:55
Conference/Events
Ocean Power to host business news update conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

AAPL

Apple

$263.82

-0.7 (-0.26%)

, UBER

Uber

$25.97

-0.73 (-2.73%)

10:53
11/14/19
11/14
10:53
11/14/19
10:53
On The Fly
Apple downgrade, Uber upgrade among today's top analyst calls »

Check out today's top…

AAPL

Apple

$263.82

-0.7 (-0.26%)

UBER

Uber

$25.97

-0.73 (-2.73%)

KHC

Kraft Heinz

$31.79

-1.1 (-3.34%)

VZ

Verizon

$59.16

-0.25 (-0.42%)

T

AT&T

$38.93

-0.22 (-0.56%)

TMUS

T-Mobile

$77.04

-0.98 (-1.26%)

ATUS

Altice USA

$26.91

0.07 (0.26%)

BYND

Beyond Meat

$81.24

2.26 (2.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 18

    Nov

  • 19

    Nov

  • 21

    Nov

  • 04

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

  • 29

    Jan

  • 30

    Jan

10:50
11/14/19
11/14
10:50
11/14/19
10:50
General news
More Powell: the long expansions have been a function of getting inflation under control »

More Powell: the long…

VTGN

VistaGen Therapeutics

$0.34

-0.7449 (-68.65%)

10:45
11/14/19
11/14
10:45
11/14/19
10:45
Downgrade
VistaGen Therapeutics rating change  »

William Blair downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CI

Cigna

$191.00

0.84 (0.44%)

10:45
11/14/19
11/14
10:45
11/14/19
10:45
Options
Cigna call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 22

    Nov

  • 09

    Dec

  • 06

    Feb

10:45
11/14/19
11/14
10:45
11/14/19
10:45
General news
FX Action: USD-JPY »

FX Action: USD-JPY hit…

10:45
11/14/19
11/14
10:45
11/14/19
10:45
General news
Breaking General news story  »

3-Month Bill Announcement…

10:45
11/14/19
11/14
10:45
11/14/19
10:45
General news
Breaking General news story  »

6-Month Bill Announcement…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.